Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

213 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Van Calster B, Collins WP, Vergote I, Van Huffel S, Valentin L; International Ovarian Tumor Analysis Group. Timmerman D, et al. Among authors: van calster b, van huffel s. J Clin Oncol. 2005 Dec 1;23(34):8794-801. doi: 10.1200/JCO.2005.01.7632. J Clin Oncol. 2005. PMID: 16314639
Preoperative identification of a suspicious adnexal mass.
Kaijser J, Sayasneh A, Van Calster B, Timmerman D, Bourne T. Kaijser J, et al. Among authors: van calster b. Gynecol Oncol. 2012 Oct;127(1):260-2. doi: 10.1016/j.ygyno.2012.07.099. Epub 2012 Jul 20. Gynecol Oncol. 2012. PMID: 22819788 No abstract available.
A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
Kaijser J, Van Gorp T, Van Hoorde K, Van Holsbeke C, Sayasneh A, Vergote I, Bourne T, Timmerman D, Van Calster B. Kaijser J, et al. Among authors: van hoorde k, van calster b, van gorp t, van holsbeke c. Gynecol Oncol. 2013 May;129(2):377-83. doi: 10.1016/j.ygyno.2013.01.018. Epub 2013 Jan 27. Gynecol Oncol. 2013. PMID: 23360924
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Vergote I, et al. Among authors: van calster b. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7. Lancet Oncol. 2019. PMID: 31076365 Clinical Trial.
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
Van Calster B, Valentin L, Froyman W, Landolfo C, Ceusters J, Testa AC, Wynants L, Sladkevicius P, Van Holsbeke C, Domali E, Fruscio R, Epstein E, Franchi D, Kudla MJ, Chiappa V, Alcazar JL, Leone FPG, Buonomo F, Coccia ME, Guerriero S, Deo N, Jokubkiene L, Savelli L, Fischerová D, Czekierdowski A, Kaijser J, Coosemans A, Scambia G, Vergote I, Bourne T, Timmerman D. Van Calster B, et al. Among authors: van holsbeke c. BMJ. 2020 Jul 30;370:m2614. doi: 10.1136/bmj.m2614. BMJ. 2020. PMID: 32732303 Free PMC article.
Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors.
Landolfo C, Achten ETL, Ceusters J, Baert T, Froyman W, Heremans R, Vanderstichele A, Thirion G, Van Hoylandt A, Claes S, Oosterlynck J, Van Rompuy AS, Schols D, Billen J, Van Calster B, Bourne T, Van Gorp T, Vergote I, Timmerman D, Coosemans A. Landolfo C, et al. Among authors: van rompuy as, van calster b, van gorp t, van hoylandt a. Gynecol Oncol. 2020 Dec;159(3):811-819. doi: 10.1016/j.ygyno.2020.09.025. Epub 2020 Sep 29. Gynecol Oncol. 2020. PMID: 32994054
A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses.
Sayasneh A, Kaijser J, Preisler J, Johnson S, Stalder C, Husicka R, Guha S, Naji O, Abdallah Y, Raslan F, Drought A, Smith AA, Fotopoulou C, Ghaem-Maghami S, Van Calster B, Timmerman D, Bourne T. Sayasneh A, et al. Among authors: van calster b. Gynecol Oncol. 2013 Jul;130(1):140-6. doi: 10.1016/j.ygyno.2013.04.003. Epub 2013 Apr 8. Gynecol Oncol. 2013. PMID: 23578539
Typical ultrasound features of various endometrial pathologies described using International Endometrial Tumor Analysis (IETA) terminology in women with abnormal uterine bleeding.
Van Den Bosch T, Verbakel JY, Valentin L, Wynants L, De Cock B, Pascual MA, Leone FPG, Sladkevicius P, Alcazar JL, Votino A, Fruscio R, Lanzani C, Van Holsbeke C, Rossi A, Jokubkiene L, Kudla M, Jakab A, Domali E, Epstein E, Van Pachterbeke C, Bourne T, Van Calster B, Timmerman D. Van Den Bosch T, et al. Among authors: van calster b, van pachterbeke c, van holsbeke c. Ultrasound Obstet Gynecol. 2021 Jan;57(1):164-172. doi: 10.1002/uog.22109. Ultrasound Obstet Gynecol. 2021. PMID: 32484286
213 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page